7.5
C
Manchester
Trending now
Rabbi Steve Karro’s Message: Give Something Back…
Global TechHouse Expands Focus on AI-Powered Technology…
[VIDEO] Beyond the cup: Korea’s evolving cafe…
Ruling party leader hit for inappropriate actions
United Airlines slashes 2026 profit outlook on…
Here’s what to expect when Netflix reports…
Walmart launches joint membership with Sam’s Club…
Seoul court again orders Japanese firm to…
General Motors is set to report earnings…
Robot factories and hypersonic missiles: JPMorgan Chase’s…
Home
News
Business
National
Press Release
Finanace
Search for:
Search
Primary Menu
Search for:
Search
Home
Business
FDA vaccine head will step down in April after string of controversial decisions
Business
FDA vaccine head will step down in April after string of controversial decisions
by
Douglas L. Grider
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
previous post
FDA reversals leave investors worrying about the fates of other experimental drugs
next post
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
Douglas L. Grider
Related posts
Peloton posts first ever annual net profit, but shares drop as outlook disappoints
Douglas L. Grider
August 6, 2026
JPMorgan Chase tops estimates as trading revenue exceeds expectations
Douglas L. Grider
January 13, 2026
Group including Jeff Bezos buys minority stake in Liverpool FC, with option to become controlling owner
Douglas L. Grider
August 14, 2026
